BioSpace News Archive

Veloxis Pharmaceuticals, an Ashai Kasei company, today announced dosing of the first patient by its partner, Xenikos, in a global pivotal Phase 3 clinical study.

Patient procedures performed at HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial with first and only FDA-authorized surgical robot with humanoid-shaped arms.

Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today the appointment of Thierry Guillaudeux, PhD to Chief Scientific Officer of the Company.

Funds to support the first-in-human clinical study of the company’s SirPlux™ Duo Drug-Coated Balloon for the treatment of de-novo coronary artery disease.

American Liver Foundation brings together experts, patients and families in a virtual two-day event.

Apnimed Granted FDA Fast Track Designation for AD109, a Novel First-in-Class Oral Pharmacologic Combination for the Treatment of Obstructive Sleep Apnea (OSA).

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company that is pioneering the development of stem cell-based delivery of oncolytic viruses, today announced the appointment of W.K. Alfred Yung, M.D., Professor, Neuro-Oncology at the MD Anderson Cancer Center, to its Medical Advisory Board.

CardieX Limited (ASX: CDX), has together with its manufacturing partner Andon filed a 510(k) premarket submission with the U.S. Food and Drug Administration (FDA) for the CONNEQT Pulse (Pulse) – a world first dual blood pressure and arterial health monitor targeted at the home health, remote patient monitoring, and decentralized clinical trial markets.

Partnership will transform ASC cardiovascular care delivery and expand patient access.

The dreaded needle-based appointments can be a thing of the past! Needle Buddies® is a syringe clip on that disguises the scary needle and syringe.